Weekly update Companies AI-cruiter Recruiting

Frontier Medicines

Founded: 2018

Location: South SF, CA

Employee range: 11 - 50

Clinical stage: Clin0

Therapy area: Oncology

Drug types: ONC

Lead product: FMC-376

Product link: https://frontiermeds.com/precision-pipeline/precision-based

Funding: $88.5M B Jul 2021; $67M A Jun 2019

Investors: Deerfield Management, Droia Oncology Ventures, MPM Capital

frontiermeds.com

linkedin.com

job board

Short description:

Drug Discovery Using Chemoproteomics Platform

Drug notes:

7 additional undisclosed programs RD oncology

Long description:

Frontier Medicines is generating medicines to treat previously undruggable disease-causing targets. Chemoproteomics is an approach to understand the interaction between small molecules and proteins in cellular contexts. Frontier is using their proprietary platform, powered by chemoproteomics along with covalent chemistry and machine learning to accelerate the discovery and development of precision medicines. The platform uses insights from proteome screening in disease relevant systems along with proprietary techniques and algorithms enabling rapid identification and assessment of actionable leads for undruggable targets. Frontier is using their platform to build a pipeline of precision medicines initially focused on oncology.